ERBB2 and neoplasm: Nbs advantages over canonical mAbs for tumour imaging were recently demonstrated in several comparison studies in xenografted mice using fluorescently labelled Nbs against HER2 10, 32, and epidermal growth factor receptor (EGFR) 33.